Tag: Kepler
Half-year review of the liquidity contract of the company Inventiva concluded with Kepler Cheuvreux – 01/24/2024 at 10:11 p.m.
Daix (France), Long Island City (New York, United States), January 24, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a biopharmaceutical company specializing in the clinical development of…
ADOCIA announces the half-yearly report of the liquidity contract concluded with the company Kepler Capital Markets – 01/17/2024 at 6:00 p.m.
ADOCIA announces the half-yearly report of the liquidity contract concluded with the company Kepler Capital Markets 6:00 p.m. CET – Under the liquidity contract entrusted to Kepler Capital Markets relating…
New sale for Unibail-Rodamco-Westfield, Kepler Chevreux to Buy
(AOF) – Unibail-Rodamco-Westfield (URW: +0.74% to 48.95 euros) announced on Monday the sale of Westfield Valencia Town Center, a regional shopping center located in Santa Clarita, California, to Centennial Real…
Nicox: Half-year report on the liquidity contract with Kepler Cheuvreux (as of June 30, 2023) – 07/11/2023 at 07:48
Under the liquidity contract entrusted by Nicox to Kepler Cheuvreux, on June 30, 2023, the following resources appeared in the liquidity account:• 304,567 titles• €10,640.56 in cash • Number of…
For Kepler Cheuvreux, the experimental treatment of Nicox against glaucoma “must improve its efficacy profile”
Posted Jan 10, 2023, 3:32 PMUpdated Jan 10, 2023, 3:34 PM Nicox has been kept out of the rebound in biotechnology stocks since the start of the year. Today, the…
GAUSSIN announces the publication of the Kepler Cheuvreux report on the Group’s outlook – 01/30/2023 at 20:36
GAUSSIN (Euronext Growth ALGAU – FR0013495298), a pioneer in clean and smart goods and passenger transport, announces that it is the subject of a report by Kepler Cheuvreux, a leading…
Half-year report on the liquidity contract of Inventiva entered into with Kepler Cheuvreux – 01/30/2023 at 10:00 p.m.
Daix (France), Long Island City (New York, United States), January 30, 2023 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a biopharmaceutical company specializing in the clinical development of…
MaaT Pharma announces the initiation of the coverage of its title by Kepler Cheuvreux – 01/27/2023 at 18:04
With a study entitled “The microbiome revolution”, Kepler Cheuvreux is today initiating coverage of MaaT Pharma with a purchase recommendation. This new coverage reinforces the visibility of the MaaT Pharma…
Global Bioenergies renews its equity financing line with Kepler Cheuvreux to support its industrial deployment – 11/11/2022 at 17:39
Global Bioenergies D news her equity financing line with Kepler Cheuvreux to accompany his dice industrial deployment Évry , the 11 nov ember 202 2 Global Bioenergies announces today the…
Global Bioenergies renews its equity financing line with Kepler Cheuvreux to support its industrial deployment – 11/11/2022 at 18:10
Evry, November 11, 2022 Global Bioenergies announces today the renewal of its equity financing line with Kepler Cheuvreux, a leading European financial services company acting as ISP under a bought…
TRANSITION EVERGREEN: Initiation of coverage by Kepler Cheuvreux – 2022-11-04 at 17:00
Paris – November 4, 2022 Transition Evergreen (FR0000035784 – EGR), 1 er investment fund listed in France dedicated to the ecological transition and the reduction of the carbon footprint, is…
Kepler Cheuvreux moves to buy Air France-KLM as third quarter results approach
A few days before the publication of its summer results, on October 28, Air France-KLM is gaining altitude on the stock market. The title of the Franco-Dutch carrier climbed 3.3%,…